Sensitive ASX Announcement

Telix Commences ZIRCON Phase III Renal Cancer Imaging Trial

Published: 23/10/18, 08:32am (AEST)2 pages
Telix Pharmaceuticals Limited
TLX:ASXHealthcare

Recent TLX Announcements

Price Sensitive only